SI1565176T1 - Sredstvo, ki ima unicujoc ucinek na maligne tumorje, in postopek za njegovo pripravo - Google Patents
Sredstvo, ki ima unicujoc ucinek na maligne tumorje, in postopek za njegovo pripravoInfo
- Publication number
- SI1565176T1 SI1565176T1 SI200330386T SI200330386T SI1565176T1 SI 1565176 T1 SI1565176 T1 SI 1565176T1 SI 200330386 T SI200330386 T SI 200330386T SI 200330386 T SI200330386 T SI 200330386T SI 1565176 T1 SI1565176 T1 SI 1565176T1
- Authority
- SI
- Slovenia
- Prior art keywords
- agent
- malignant tumors
- destructive effect
- production
- hydroxymethylfurfural
- Prior art date
Links
- 201000011510 cancer Diseases 0.000 title abstract 2
- 230000001066 destructive effect Effects 0.000 title abstract 2
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 abstract 2
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 abstract 2
- NOEGNKMFWQHSLB-UHFFFAOYSA-N 5-hydroxymethylfurfural Chemical compound OCC1=CC=C(C=O)O1 NOEGNKMFWQHSLB-UHFFFAOYSA-N 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- RJGBSYZFOCAGQY-UHFFFAOYSA-N hydroxymethylfurfural Natural products COC1=CC=C(C=O)O1 RJGBSYZFOCAGQY-UHFFFAOYSA-N 0.000 abstract 2
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 abstract 1
- SBJKKFFYIZUCET-UHFFFAOYSA-N Dehydroascorbic acid Natural products OCC(O)C1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-UHFFFAOYSA-N 0.000 abstract 1
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 abstract 1
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 abstract 1
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 235000020960 dehydroascorbic acid Nutrition 0.000 abstract 1
- 239000011615 dehydroascorbic acid Substances 0.000 abstract 1
- 238000001802 infusion Methods 0.000 abstract 1
- 230000002262 irrigation Effects 0.000 abstract 1
- 238000003973 irrigation Methods 0.000 abstract 1
- 229940043353 maltol Drugs 0.000 abstract 1
- 238000011275 oncology therapy Methods 0.000 abstract 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 abstract 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 abstract 1
- 235000012141 vanillin Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0177802A AT412447B (de) | 2002-11-27 | 2002-11-27 | Mittel mit zerstörender wirkung auf maligne tumore sowie verfahren zu seiner herstellung |
| PCT/EP2003/050712 WO2004047832A1 (de) | 2002-11-27 | 2003-10-13 | Mittel mit zerstörender wirkung auf maligne tumore sowie verfahren zu seiner herstellung |
| EP03778338A EP1565176B1 (de) | 2002-11-27 | 2003-10-13 | Mittel mit zerstörender wirkung auf maligne tumore sowie verfahren zu seiner herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1565176T1 true SI1565176T1 (sl) | 2006-10-31 |
Family
ID=32330381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200330386T SI1565176T1 (sl) | 2002-11-27 | 2003-10-13 | Sredstvo, ki ima unicujoc ucinek na maligne tumorje, in postopek za njegovo pripravo |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7855191B2 (sl) |
| EP (1) | EP1565176B1 (sl) |
| JP (1) | JP4745665B2 (sl) |
| AT (2) | AT412447B (sl) |
| AU (1) | AU2003285351B2 (sl) |
| CA (1) | CA2507273A1 (sl) |
| CY (1) | CY1105392T1 (sl) |
| DE (1) | DE50303513D1 (sl) |
| DK (1) | DK1565176T3 (sl) |
| ES (1) | ES2268452T3 (sl) |
| PT (1) | PT1565176E (sl) |
| SI (1) | SI1565176T1 (sl) |
| WO (1) | WO2004047832A1 (sl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL372183A1 (pl) * | 2005-01-11 | 2006-07-24 | Sgp & Sons Ab | Preparat przeciwnowotworowy oraz zastosowanie preparatu przeciwnowotworowego |
| JP4693093B2 (ja) * | 2005-01-27 | 2011-06-01 | 国立大学法人 鹿児島大学 | 抗癌剤 |
| AT503385B1 (de) * | 2006-03-20 | 2008-05-15 | C Y L Pharmazeutika Gmbh | Mittel zur behandlung von oxidativem stress |
| BRPI1101935B1 (pt) * | 2011-04-15 | 2017-12-12 | Universidade Federal De Minas Gerais | Antioxidant composition for preservation of organs and fabrics |
| DE102013106530A1 (de) * | 2013-06-21 | 2014-12-24 | Christoph Pallua | Krebsmedikament |
| US20210283095A1 (en) * | 2020-03-11 | 2021-09-16 | Harold E. Siess | Detection and Treatment of Viral Diseases and Cancer |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3542309A1 (de) * | 1985-11-29 | 1987-06-04 | Cardona Federico Dr | Medizinisches antioxidativum |
| AT393221B (de) * | 1988-02-03 | 1991-09-10 | Leopold Pharma Gmbh | Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken |
| WO2000067762A2 (en) * | 1999-05-11 | 2000-11-16 | Anticancer, Inc. | Selenium-containing pro-drugs for cancer therapy |
| US20050260277A1 (en) * | 2001-02-28 | 2005-11-24 | Giles Brian C | Method and formula for anti-tumor and anti-matastatic effect |
-
2002
- 2002-11-27 AT AT0177802A patent/AT412447B/de not_active IP Right Cessation
-
2003
- 2003-10-13 CA CA002507273A patent/CA2507273A1/en not_active Abandoned
- 2003-10-13 PT PT03778338T patent/PT1565176E/pt unknown
- 2003-10-13 EP EP03778338A patent/EP1565176B1/de not_active Expired - Lifetime
- 2003-10-13 US US10/536,777 patent/US7855191B2/en active Active
- 2003-10-13 DK DK03778338T patent/DK1565176T3/da active
- 2003-10-13 WO PCT/EP2003/050712 patent/WO2004047832A1/de active Application Filing
- 2003-10-13 JP JP2004554531A patent/JP4745665B2/ja not_active Expired - Fee Related
- 2003-10-13 AT AT03778338T patent/ATE326958T1/de not_active IP Right Cessation
- 2003-10-13 SI SI200330386T patent/SI1565176T1/sl unknown
- 2003-10-13 DE DE50303513T patent/DE50303513D1/de not_active Expired - Lifetime
- 2003-10-13 ES ES03778338T patent/ES2268452T3/es not_active Expired - Lifetime
- 2003-10-13 AU AU2003285351A patent/AU2003285351B2/en not_active Expired
-
2006
- 2006-08-23 CY CY20061101167T patent/CY1105392T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1565176E (pt) | 2006-10-31 |
| US7855191B2 (en) | 2010-12-21 |
| CY1105392T1 (el) | 2010-04-28 |
| AU2003285351A8 (en) | 2004-06-18 |
| CA2507273A1 (en) | 2004-06-10 |
| ATE326958T1 (de) | 2006-06-15 |
| EP1565176B1 (de) | 2006-05-24 |
| AU2003285351B2 (en) | 2010-07-01 |
| JP4745665B2 (ja) | 2011-08-10 |
| AT412447B (de) | 2005-03-25 |
| AU2003285351A1 (en) | 2004-06-18 |
| WO2004047832A1 (de) | 2004-06-10 |
| EP1565176A1 (de) | 2005-08-24 |
| ATA17782002A (de) | 2004-08-15 |
| DE50303513D1 (de) | 2006-06-29 |
| JP2006508998A (ja) | 2006-03-16 |
| US20060292218A1 (en) | 2006-12-28 |
| ES2268452T3 (es) | 2007-03-16 |
| DK1565176T3 (da) | 2006-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG25822A (en) | Quinolinyl-pyrrolopyrazoles | |
| WO2003002595A3 (en) | Dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents | |
| MXPA03011681A (es) | Uso de inhibidores de epoxido hidrolasa soluble, para tratar enfermedades relacionadas con la enfermedad cardiovascular. | |
| BG108318A (en) | Carboxamide-substituted phenylurea derivatives and method for the production and use thereof as medicaments | |
| AU2003267203A1 (en) | Method for administering thermotherapy to prevent the growth of tumors | |
| ZA200603538B (en) | P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same | |
| TW200510375A (en) | New compounds | |
| MY144659A (en) | 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors | |
| GEP20063895B (en) | Platinum derivative pharmaceutical formulations | |
| WO2003070163A3 (en) | Prostacyclin derivatives for treating cancer | |
| WO2003103603A3 (en) | NEW FORMIATE-TYPE SALT OF O-DESMETHYLVENLAFAXINE | |
| NO20050428L (no) | Arylkarbonylpiperaziner og heteroarylkarbonylpiperaziner og anvendelse derav for behandling av godartede og ondartede tumorsykdommer | |
| EA200401622A1 (ru) | Способы лечения ангиогенеза, роста опухолей и метастазов | |
| PL342614A1 (en) | Anticarcinogenic drugs | |
| MX2007006927A (es) | Combinacion de inhibidor de tirosina cinasa y her-2/neu para terapia de cancer. | |
| AU2003285351A8 (en) | Agent having a destructive effect on malignant tumors and method for the production thereof | |
| TR200402230T4 (tr) | O-ikameli 6-metil-tramadol-türevleri | |
| ATE339202T1 (de) | Verwendung von alpha-halogenacryloyl-distamycin derivaten zur herstellung eines medikaments zur behandlung von krebs | |
| NO20030420D0 (no) | Medikament for immunoterapi av maligne tumorer | |
| WO2001076597A3 (en) | A method of administering an antitumour compound using a polymer-camptothecin conjugate | |
| EP1547596A4 (en) | MEDICAL COMPOSITION AND METHOD FOR THE TREATMENT OF MALIGNANT TUMORS AND THE USE THEREOF | |
| WO2005014542A3 (de) | Neue n-substituierte indolyl-3-glyoxylsäureamide, deren verwendung als arzneimittel gegen krebs und verfahren zu deren herstellung | |
| SE0101257D0 (sv) | Treatment of whiplash associated disorder | |
| DE50304524D1 (de) | Arzneimittel enthaltend substituierte 2,5-diaminomethyl-1h-pyrrole | |
| AU2003251446A1 (en) | Formulation of liposomal derivatives of phenylalanine |